ID   M3K8_RAT                Reviewed;         467 AA.
AC   Q63562;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 148.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 8;
DE            EC=2.7.11.25;
DE   AltName: Full=Tumor progression locus 2;
DE            Short=TPL-2;
GN   Name=Map3k8; Synonyms=Tpl2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Long Evans; TISSUE=Liver;
RX   PubMed=7681591; DOI=10.1073/pnas.90.6.2251;
RA   Patriotis C., Makris A., Bear S.E., Tsichlis P.N.;
RT   "Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the
RT   progression of rodent T-cell lymphomas and in T-cell activation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:2251-2255(1993).
RN   [2]
RP   INTERACTION WITH NFKB1.
RX   PubMed=9950430; DOI=10.1038/16946;
RA   Belich M.P., Salmeron A., Johnston L.H., Ley S.C.;
RT   "TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein
RT   NF-kappaB1 p105.";
RL   Nature 397:363-368(1999).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138 AND SER-141, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Required for lipopolysaccharide (LPS)-induced, TLR4-mediated
CC       activation of the MAPK/ERK pathway in macrophages, thus being critical
CC       for production of the pro-inflammatory cytokine TNF-alpha (TNF) during
CC       immune responses. Involved in the regulation of T-helper cell
CC       differentiation and IFNG expression in T-cells. Involved in mediating
CC       host resistance to bacterial infection through negative regulation of
CC       type I interferon (IFN) production. Transduces CD40 and TNFRSF1A
CC       signals that activate ERK in B-cells and macrophages, and thus may play
CC       a role in the regulation of immunoglobulin production. May also play a
CC       role in the transduction of TNF signals that activate JNK and NF-kappa-
CC       B in some cell types. In adipocytes, activates MAPK/ERK pathway in an
CC       IKBKB-dependent manner in response to IL1B and TNF, but not insulin,
CC       leading to induction of lipolysis. Plays a role in the cell cycle.
CC       {ECO:0000269|PubMed:7681591}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.25;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.25;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Forms a ternary complex with NFKB1/p105 and TNIP2. Interacts
CC       with NFKB1; the interaction increases the stability of MAP3K8 but
CC       inhibits its MEK phosphorylation activity, whereas loss of interaction
CC       following LPS stimulation leads to its degradation. Interacts with CD40
CC       and TRAF6; the interaction is required for ERK activation. Interacts
CC       with KSR2; the interaction inhibits ERK and NF-kappa-B activation.
CC       {ECO:0000269|PubMed:9950430}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in spleen, thymus, liver and lung.
CC       {ECO:0000269|PubMed:7681591}.
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M94454; AAA42185.1; -; mRNA.
DR   PIR; A47388; A47388.
DR   RefSeq; NP_446299.1; NM_053847.1.
DR   AlphaFoldDB; Q63562; -.
DR   SMR; Q63562; -.
DR   STRING; 10116.ENSRNOP00000022190; -.
DR   iPTMnet; Q63562; -.
DR   PhosphoSitePlus; Q63562; -.
DR   PaxDb; 10116-ENSRNOP00000022190; -.
DR   GeneID; 116596; -.
DR   KEGG; rno:116596; -.
DR   UCSC; RGD:620969; rat.
DR   AGR; RGD:620969; -.
DR   CTD; 1326; -.
DR   RGD; 620969; Map3k8.
DR   eggNOG; KOG0201; Eukaryota.
DR   InParanoid; Q63562; -.
DR   OrthoDB; 5342116at2759; -.
DR   PhylomeDB; Q63562; -.
DR   Reactome; R-RNO-389357; CD28 dependent PI3K/Akt signaling.
DR   PRO; PR:Q63562; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IDA:RGD.
DR   GO; GO:0004672; F:protein kinase activity; IDA:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0003231; P:cardiac ventricle development; IEP:RGD.
DR   GO; GO:1990349; P:gap junction-mediated intercellular transport; IMP:RGD.
DR   GO; GO:0002376; P:immune system process; IEA:UniProtKB-KW.
DR   CDD; cd13995; STKc_MAP3K8; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR050538; MAP_kinase_kinase_kinase.
DR   InterPro; IPR017424; MAPKKK8.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR48016; MAP KINASE KINASE KINASE SSK2-RELATED-RELATED; 1.
DR   PANTHER; PTHR48016:SF31; MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 8; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF038171; MAPKKK8; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell cycle; Cytoplasm; Immunity; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..467
FT                   /note="Mitogen-activated protein kinase kinase kinase 8"
FT                   /id="PRO_0000086257"
FT   DOMAIN          146..388
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        253
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         144..152
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         167
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         80
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P41279"
FT   MOD_RES         138
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         141
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         290
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P41279"
FT   MOD_RES         400
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P41279"
FT   MOD_RES         443
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P41279"
SQ   SEQUENCE   467 AA;  52807 MW;  454E0E32768A4ABD CRC64;
     MEYMSTGSDE KEEIDLLINH LNVSEVLDIM ENLYASEEPA VYEPSLMTMC PDSNQNKEHS
     ESLLRSGQEV PWLSSVRYGT VEDLLAFANH ISNTTKHFYR CRPQESGILL NMVISPQNGR
     YQIDSDVLLV PWKLTYRSIG SGFVPRGAFG KVYLAQDMKT KKRMACKLIP VDQFKPSDVE
     IQACFRHENI AELYGAVLWG DTVHLFMEAG EGGSVLEKLE SCGPMREFEI IWVTKHVLKG
     LDFLHSKKVI HHDIKPSNIV FMSTKAVLVD FGLSVQMTED VYLPKDLRGT EIYMSPEVIL
     CRGHSTKADI YSLGATLIHM QTGTPPWVKR YPRSAYPSYL YIIHKQAPPL EDIAGDCSPG
     MRELIEAALE RNPNHRPKAA DLLKHEALNP PREDQPRCQS LDSALFDRKR LLSRKELELP
     ENIADSSCTG STEESEVLRR QRSLYIDLGA LAGYFNIVRG PPTLEYG
//
